by Amy Adams on February 10, 2011 at 12:15PM | comments
It seems like the stem cell news cycle alternates between stories of incremental hope (take the heart disease model for drug discovery out of Stanford today) and stories decrying the woeful lack of cures out of CIRM. I think the popular imagination went from the word "cure" when Proposition 71 passed in 2004 to an immediate need to see those cures by 2005. Or at least by 2011.
by Amy Adams on September 24, 2010 at 11:58AM | comments
A nod to Paul Knoepfler at UC Davis, who has posted a blog entry about the Geron trial for spinal cord injury. It provides a nice summary of the science behind the trial, and a reminder of why patients might be hard to recruit. He refers to Michael Martinez, a jockey who recently sustained a severe spinal cord injury, and who was rejected for participation in Geron's trial developed from human embryonic stem cells. As Knoepfler points out: